These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 3479311)
1. Neopterin. A tumor marker in colorectal carcinoma? Putzki H; Aschern F; Henkel E; Heymann H Dis Colon Rectum; 1987 Nov; 30(11):879-83. PubMed ID: 3479311 [TBL] [Abstract][Full Text] [Related]
2. Sensitivity of monoclonal antibodies to carcinoembryonic antigen, tissue polypeptide antigen, alpha-fetoprotein, carbohydrate antigen 50, and carbohydrate antigen 19-9 in the diagnosis of colorectal adenocarcinoma. Alvarez JA; Marín J; Jover JM; Fernández R; Fradejas J; Moreno M Dis Colon Rectum; 1995 May; 38(5):535-42. PubMed ID: 7537651 [TBL] [Abstract][Full Text] [Related]
3. Evaluation of seven different tumour markers for the establishment of tumour marker panels in gynecologic malignancies. Avall Lundqvist E; Nordström L; Sjövall K; Eneroth P Eur J Gynaecol Oncol; 1989; 10(6):395-405. PubMed ID: 2627971 [TBL] [Abstract][Full Text] [Related]
4. [Utility of CA19-9 and CEA as tumor marker in colorectal cancer--comparison between serum level and distribution]. Okuda K; Kodaira S; Watanabe M; Takami H; Teramoto T; Abe O; Iri H; Ino Y; Hirohashi S Nihon Gan Chiryo Gakkai Shi; 1986 Jun; 21(5):969-77. PubMed ID: 3463631 [No Abstract] [Full Text] [Related]
5. [Ca 12-5 in stomach and colorectal cancer. A comparison with the tumor markers CEA and Ca 19-9]. Quentmeier A; Schlag P; Geisen HP; Schmidt-Gayk H Med Klin (Munich); 1986 Mar; 81(6):199-201. PubMed ID: 3466003 [No Abstract] [Full Text] [Related]
6. Tumor markers carcinoembryonic antigen, tissue polypeptide antigen, and carbohydrate antigen 19/9 in liver diseases. Putzki H; Ledwoch J; Student A; Jablonski M; Heymann H J Surg Oncol; 1988 Feb; 37(2):133-5. PubMed ID: 3278167 [TBL] [Abstract][Full Text] [Related]
7. Comparison of the tumor markers CEA, TPA, and CA 19-9 in colorectal carcinoma. Putzki H; Student A; Jablonski M; Heymann H Cancer; 1987 Jan; 59(2):223-6. PubMed ID: 3467817 [TBL] [Abstract][Full Text] [Related]
8. The clinical value of the tumor markers CA 19/9 and carcinoembryonic antigen (CEA) in colorectal carcinomas: a critical comparison. von Kleist S Int J Biol Markers; 1986; 1(1):3-8. PubMed ID: 3480321 [TBL] [Abstract][Full Text] [Related]
9. Biochemical and immunologic diagnosis of cancer. Colorectal cancer. von Kleist S Tumour Biol; 1987; 8(2-3):78-83. PubMed ID: 3329404 [No Abstract] [Full Text] [Related]
10. Measurement of CEA, TPA, neopterin, CA125, CA153 and CA199 in sera of pregnant women, umbilical cord blood and amniotic fluid. Lellé RJ; Henkel E; Leinemann D; Goeschen K Gynecol Obstet Invest; 1989; 27(3):137-42. PubMed ID: 2737547 [TBL] [Abstract][Full Text] [Related]
11. The value of CA 19-9 in gastric and colorectal carcinoma. Safi F; Bittner R; Roscher R; Kübel R; Beger HG Cancer Invest; 1987; 5(5):401-7. PubMed ID: 3480768 [TBL] [Abstract][Full Text] [Related]
12. [Clinical evaluation of tumor markers in patients with colorectal cancer]. Naritaka Y; Ogawa K; Matsumoto N; Hosokawa T; Kikuchi T; Koyama N; Haga S; Kajiwara T; Sakakibara N Gan No Rinsho; 1987 Aug; 33(10):1274-80. PubMed ID: 2444727 [TBL] [Abstract][Full Text] [Related]
13. Carcinoembryonic antigen, CA 19-9, and CA 125 in normal and carcinomatous human colorectal tissue. Quentmeier A; Möller P; Schwarz V; Abel U; Schlag P Cancer; 1987 Nov; 60(9):2261-6. PubMed ID: 3481558 [TBL] [Abstract][Full Text] [Related]
14. [Diagnosis and treatment of colorectal cancer using monoclonal antibodies]. Inagi H; Okuda H; Shimano T; Kadota T; Mori T Gan To Kagaku Ryoho; 1986 Jul; 13(7):2291-7. PubMed ID: 3460528 [TBL] [Abstract][Full Text] [Related]
15. [Value of neopterin as an oncologic laboratory parameter--observations in gynecologic tumors]. von Broen B; Kavungu P Z Gesamte Inn Med; 1990 Apr; 45(8):223-5. PubMed ID: 2378135 [TBL] [Abstract][Full Text] [Related]
16. [Comparison of the tumor markers CEA and CA 19-9 in colorectal diagnosis]. Heptner G; Domschke S; Krapf F; Schneider MU; Iro H; Domschke W Dtsch Med Wochenschr; 1984 Aug; 109(35):1309-12. PubMed ID: 6590287 [TBL] [Abstract][Full Text] [Related]
17. The clinical validity of circulating tumor-associated antigens CEA and CA 19-9 in primary diagnosis and follow-up of patients with gastrointestinal malignancies. Staab HJ; Brümmendorf T; Hornung A; Anderer FA; Kieninger G Klin Wochenschr; 1985 Feb; 63(3):106-15. PubMed ID: 3856076 [TBL] [Abstract][Full Text] [Related]
18. [Significance of CEA and CA242 in the diagnosis of colorectal carcinoma]. Wu J; Yu H; Shao Y Zhonghua Zhong Liu Za Zhi; 1995 Nov; 17(6):438-40. PubMed ID: 8697997 [TBL] [Abstract][Full Text] [Related]
19. [Carbohydrate antigen 19-9 (CA 19-9) and carcinoembryonic antigen in gastrointestinal neoplasms. Comparison of markers]. Capocasale E; Contini S; Rossetti A; Del Sante G; Gregori G Acta Biomed Ateneo Parmense; 1985; 56(6):231-6. PubMed ID: 2940782 [TBL] [Abstract][Full Text] [Related]
20. Value of serum levels of carcinoembryonic antigen, CEA, and gastrointestinal cancer antigen, GICA or CA 19-9, for preoperative staging and postoperative monitoring of patients with colorectal carcinoma. Szymendera JJ; Nowacki MP; Kozłowicz-Gudzińska I; Kowalska M Dis Colon Rectum; 1985 Dec; 28(12):895-9. PubMed ID: 3864628 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]